Drug Shortage Report for INNOHEP
| Report ID | 100375 |
| Drug Identification Number | 02167840 |
| Brand name | INNOHEP |
| Common or Proper name | tinzaparin sodium |
| Company Name | LEO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TINZAPARIN SODIUM |
| Strength(s) | 10000UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 10 x 2mL vials |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-12-05 |
| Actual start date | |
| Estimated end date | 2020-02-17 |
| Actual end date | 2020-01-31 |
| Shortage status | Resolved |
| Updated date | 2020-02-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3389 STEELES AVENUE EAST, SUITE 110 TORONTO, ONTARIO CANADA M2H 3S8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-02-03 | French | Compare |
| v4 | 2020-02-03 | English | Compare |
| v3 | 2019-12-06 | English | Compare |
| v2 | 2019-12-05 | French | Compare |
| v1 | 2019-12-05 | English | Compare |
Showing 1 to 5 of 5